Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.04.002
Miguel A. Medina-Andrade , Ítalo D. Masini-Aguilera , Jaime Lopez-Taylor , David Ramírez-Cedillo , Carlos A. Jimenez-Fernandez , Nancy Erika Medina Martinez , Rocio A. Peña-Juárez
Cantrelĺs pentalogy is an extremely rare syndrome associating with ectopia cordis and various degrees of midline defects. We present the case of patient with pentalogy of Cantrell with ectopia complete cordis without serious intracardiac anomalies, performing cardiac reduction towards the mediastinum with adequate evolution.
{"title":"Reparación de ectopia cordis asociada con pentalogía de Cantrell, presentación de un caso","authors":"Miguel A. Medina-Andrade , Ítalo D. Masini-Aguilera , Jaime Lopez-Taylor , David Ramírez-Cedillo , Carlos A. Jimenez-Fernandez , Nancy Erika Medina Martinez , Rocio A. Peña-Juárez","doi":"10.1016/j.circv.2024.04.002","DOIUrl":"10.1016/j.circv.2024.04.002","url":null,"abstract":"<div><div>Cantrelĺs pentalogy is an extremely rare syndrome associating with ectopia cordis and various degrees of midline defects. We present the case of patient with pentalogy of Cantrell with ectopia complete cordis without serious intracardiac anomalies, performing cardiac reduction towards the mediastinum with adequate evolution.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 23-25"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141710663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.11.002
Alberto Juffé Stein , Federico Menéndez Osorio
{"title":"El poder de la palabra en la curación del paciente","authors":"Alberto Juffé Stein , Federico Menéndez Osorio","doi":"10.1016/j.circv.2024.11.002","DOIUrl":"10.1016/j.circv.2024.11.002","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 1-2"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143143573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.05.008
Mario Castaño, Pasquale Maiorano, Laura Castillo, Blanca Meana, Belén Ramos, Elio Martín-Gutiérrez, Javier A. Gualis
Procalcitonin is a valuable biomarker for the diagnosis and prognosis of infection and for antibiotic treatment monitoring in multiple clinical situations. Postoperative infection is a severe complication after cardiac surgery that increases morbimortality, which can be effectively reduced with early detection and appropriate treatment. Surgical trauma and cardiopulmonary bypass induced inflammation, as well as hypothermia or vasoconstrictors, stimulate the release of procalcitonin in uncomplicated postoperative patients, so its usefulness may be reduced. This review presents the state of the art regarding the predictive value of procalcitonin as a clinical biomarker for the diagnosis and prognosis of infection in various clinical contexts and the current evidence of the usefulness of this biomarker in the diagnosis and prognosis of infectious and non-infectious complications in the cardiac postoperative period.
{"title":"Utilidad de la procalcitonina como biomarcador en cirugía cardiaca","authors":"Mario Castaño, Pasquale Maiorano, Laura Castillo, Blanca Meana, Belén Ramos, Elio Martín-Gutiérrez, Javier A. Gualis","doi":"10.1016/j.circv.2024.05.008","DOIUrl":"10.1016/j.circv.2024.05.008","url":null,"abstract":"<div><div>Procalcitonin is a valuable biomarker for the diagnosis and prognosis of infection and for antibiotic treatment monitoring in multiple clinical situations. Postoperative infection is a severe complication after cardiac surgery that increases morbimortality, which can be effectively reduced with early detection and appropriate treatment. Surgical trauma and cardiopulmonary bypass induced inflammation, as well as hypothermia or vasoconstrictors, stimulate the release of procalcitonin in uncomplicated postoperative patients, so its usefulness may be reduced. This review presents the state of the art regarding the predictive value of procalcitonin as a clinical biomarker for the diagnosis and prognosis of infection in various clinical contexts and the current evidence of the usefulness of this biomarker in the diagnosis and prognosis of infectious and non-infectious complications in the cardiac postoperative period.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 26-33"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143143577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.07.009
Audelio Guevara-Bonilla, Eduardo Tébar-Botí, Claudia Aguirre-Ramón, Alexandra Merino-Orozco, Carlos Domínguez-Massa, Manuel Pérez-Guillén, Ana Bel-Mínguez, Salvador Torregrosa-Puerta, Tomás Heredia-Cambra, Alejandro Rincón-Almanza, María J. Dalmau-Sorli, Iván Martín González, Francisco J. Valera Martínez, Ana Tur-Alonso, Juan B. Martínez León
Introduction
In Spain, since 2020, hearts obtained from donation after circulatory determination of death (DCD) have been used for heart transplants. We show our experience from the beginning of the heart DCDs program. An out-of-hospital cardiac extraction protocol has been implemented within the Valencian Community.
Materials and method
From November 2022 to April 2024, 21 cardiac assessments have been performed in the context of DCD.
Donor inclusion criteria: donor < 55 years old; family donation consent; functional warm ischemia time < 30 min.
Donor exclusion criteria, additional to those of a cardiac donation: adrenaline infusion; dobutamine infusion; norepinephrine infusion > 0,3 μg/kg/min.
This is a retrospective descriptive study.
Results
Of the 21 possible donors, 19 were valid hearts, 2 of them were for a hospital outside the community. The mean age of the donors was 40.4 years, most of them men. In total, 17 patients were transplanted in our hospital. The mean cardiac ischemia time was 136.41 min. Primary graft failure was described in 8 patients.
Conclusions
The cardiopulmonary bypass allowed continuous monitoring of aerobic and anaerobic metabolism, correct emptying of the cardiac chambers and the administration of cardioplegia with pressure, temperature and flow control.
Our experience highlights the possibilities of success with hearts obtained from a DCD, representing an increase in the number of donors and a decrease in the waiting time for the transplant.
在西班牙，自2020年以来，在循环确定死亡（DCD）后捐赠的心脏已用于心脏移植。我们展示了我们从心脏dcd项目开始的经验。在巴伦西亚社区实施了院外心脏摘取协议。材料与方法从2022年11月至2024年4月，在DCD背景下进行了21例心脏评估。捐赠者入选标准：捐赠者<；55岁；家属捐赠同意书；功能性热缺血时间<；30分钟。除心脏捐赠外的供者排除标准：肾上腺素输注；多巴酚丁胺输液;去甲肾上腺素输注；0、3μg / kg /分钟。这是一项回顾性描述性研究。结果21例可能供体中，19例为有效供体，其中2例为社区外医院供体。捐赠者的平均年龄为40.4岁，其中大多数是男性。本院共移植17例。平均心脏缺血时间为136.41 min。8例患者出现原发性移植物衰竭。结论体外循环可以持续监测患者的有氧和无氧代谢，正确排空心室，并在控制压力、温度和流量的情况下给予心脏骤停。我们的经验强调了从DCD获得心脏的成功可能性，这代表了供体数量的增加和移植等待时间的减少。
{"title":"Experiencia en DAC cardiaca en la Comunidad Valenciana: programa de extracción cardiaca extrahospitalaria","authors":"Audelio Guevara-Bonilla, Eduardo Tébar-Botí, Claudia Aguirre-Ramón, Alexandra Merino-Orozco, Carlos Domínguez-Massa, Manuel Pérez-Guillén, Ana Bel-Mínguez, Salvador Torregrosa-Puerta, Tomás Heredia-Cambra, Alejandro Rincón-Almanza, María J. Dalmau-Sorli, Iván Martín González, Francisco J. Valera Martínez, Ana Tur-Alonso, Juan B. Martínez León","doi":"10.1016/j.circv.2024.07.009","DOIUrl":"10.1016/j.circv.2024.07.009","url":null,"abstract":"<div><h3>Introduction</h3><div>In Spain, since 2020, hearts obtained from donation after circulatory determination of death (DCD) have been used for heart transplants. We show our experience from the beginning of the heart DCDs program. An out-of-hospital cardiac extraction protocol has been implemented within the Valencian Community.</div></div><div><h3>Materials and method</h3><div>From November 2022 to April 2024, 21 cardiac assessments have been performed in the context of DCD.</div><div>Donor inclusion criteria: donor <<!--> <!-->55<!--> <!-->years old; family donation consent; functional warm ischemia time <<!--> <!-->30<!--> <!-->min.</div><div>Donor exclusion criteria, additional to those of a cardiac donation: adrenaline infusion; dobutamine infusion; norepinephrine infusion ><!--> <!-->0,3<!--> <!-->μg/kg/min.</div><div>This is a retrospective descriptive study.</div></div><div><h3>Results</h3><div>Of the 21 possible donors, 19 were valid hearts, 2 of them were for a hospital outside the community. The mean age of the donors was 40.4<!--> <!-->years, most of them men. In total, 17 patients were transplanted in our hospital. The mean cardiac ischemia time was 136.41<!--> <!-->min. Primary graft failure was described in 8 patients.</div></div><div><h3>Conclusions</h3><div>The cardiopulmonary bypass allowed continuous monitoring of aerobic and anaerobic metabolism, correct emptying of the cardiac chambers and the administration of cardioplegia with pressure, temperature and flow control.</div><div>Our experience highlights the possibilities of success with hearts obtained from a DCD, representing an increase in the number of donors and a decrease in the waiting time for the transplant.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 5-8"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143143580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.08.002
Consuelo M. Sisinni-Ganly, Julio C. Lugo-Adán, Francisco Estévez-Cid, Rocío Casais-Pampín, Juan J. Legarra-Calderón
Background
Ross surgery is a relatively infrequent procedure due to its technical complexity and its long-term outcomes not being exempt from controversy. We analyzed the outcomes of our series of patients undergoing the Ross procedure and those who required reintervention due to dysfunction of the pulmonary autograft or homograft.
Methods
Since 1998, 108 patients underwent Ross surgery at our center, with root replacement (RR) surgical technique used in 105 of them. We retrospectively reviewed data from a subgroup of patients who underwent reintervention after Ross surgery due to dysfunction of the autograft or homograft. Their characteristics and survival were studied using Kaplan-Meier analysis.
Results
The mean follow-up of the patients undergoing RR was 17.5 ± 5 years (median 19 years, range 0-25 years). During this period, 29 patients (26.9%) required at least one reintervention: 13 patients (44.8%) due to autograft dysfunction, 7 patients (24.1%) due to homograft dysfunction, and 9 patients (31%) due to dysfunction of both autograft and homograft. The mean time to reintervention due to autograft dysfunction was 11.8 ± 5.2 years (median 12 years, range 2-19 years) and due to homograft dysfunction was 12.6 ± 5 years (median 13 years, range 2-19 years). Hospital mortality was null. The follow-up of these reintervened patients was 18.7 ± 3.1 years (median 19 years, range 9-23), and the mortality during this period was 10% (n = 3): two due to cardiac causes and one due to non-cardiac causes. The cumulative survival function of patients who underwent reintervention at 10 years was 100%, and at 20 years it was 93%.
Conclusions
The Ross procedure is associated with a non-negligible risk of reoperation. In our series of patients, no early mortality has been observed following reoperation due to dysfunction of the pulmonary autograft or homograft.
{"title":"25 años de cirugía de Ross: seguimiento y resultados en pacientes reoperados en nuestro centro","authors":"Consuelo M. Sisinni-Ganly, Julio C. Lugo-Adán, Francisco Estévez-Cid, Rocío Casais-Pampín, Juan J. Legarra-Calderón","doi":"10.1016/j.circv.2024.08.002","DOIUrl":"10.1016/j.circv.2024.08.002","url":null,"abstract":"<div><h3>Background</h3><div>Ross surgery is a relatively infrequent procedure due to its technical complexity and its long-term outcomes not being exempt from controversy. We analyzed the outcomes of our series of patients undergoing the Ross procedure and those who required reintervention due to dysfunction of the pulmonary autograft or homograft.</div></div><div><h3>Methods</h3><div>Since 1998, 108 patients underwent Ross surgery at our center, with root replacement (RR) surgical technique used in 105 of them. We retrospectively reviewed data from a subgroup of patients who underwent reintervention after Ross surgery due to dysfunction of the autograft or homograft. Their characteristics and survival were studied using Kaplan-Meier analysis.</div></div><div><h3>Results</h3><div>The mean follow-up of the patients undergoing RR was 17.5<!--> <!-->±<!--> <!-->5<!--> <!-->years (median 19<!--> <!-->years, range 0-25<!--> <!-->years). During this period, 29 patients (26.9%) required at least one reintervention: 13 patients (44.8%) due to autograft dysfunction, 7 patients (24.1%) due to homograft dysfunction, and 9 patients (31%) due to dysfunction of both autograft and homograft. The mean time to reintervention due to autograft dysfunction was 11.8<!--> <!-->±<!--> <!-->5.2<!--> <!-->years (median 12<!--> <!-->years, range 2-19<!--> <!-->years) and due to homograft dysfunction was 12.6<!--> <!-->±<!--> <!-->5<!--> <!-->years (median 13<!--> <!-->years, range 2-19<!--> <!-->years). Hospital mortality was null. The follow-up of these reintervened patients was 18.7<!--> <!-->±<!--> <!-->3.1<!--> <!-->years (median 19<!--> <!-->years, range 9-23), and the mortality during this period was 10% (n<!--> <!-->=<!--> <!-->3): two due to cardiac causes and one due to non-cardiac causes. The cumulative survival function of patients who underwent reintervention at 10<!--> <!-->years was 100%, and at 20<!--> <!-->years it was 93%.</div></div><div><h3>Conclusions</h3><div>The Ross procedure is associated with a non-negligible risk of reoperation. In our series of patients, no early mortality has been observed following reoperation due to dysfunction of the pulmonary autograft or homograft.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 14-20"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143143576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.08.001
Marta Molina , Elena Roselló , Manel Tauron , Juan F. Tabilo , Constanza Fernandez , Carla Gotsens , Exzequiel Pueblas , José Montiel , Sandra Casellas , Angela Irabien , Laura Corominas , Laura López , Sonia Mirabet , Antonino Ginel
Introduction and objectives
Survival and the need for transplantation in patients with congenital heart disease have increased. This study aims to understand the perioperative characteristics and long-term survival of these patients after transplantation and to compare them with those of patients with non-congenital heart disease.
Methods
Patients who underwent a heart transplant at our center from 1984 to 2023 were included. A retrospective cohort study (congenital/non-congenital) with long-term follow-up was conducted. Statistical analysis was performed using Stata.
Results
A total of 636 transplanted patients were included, of which 37 had congenital heart disease. The number of transplanted patients with congenital heart disease has increased; 59.5% of such patients was transplanted in the last 10 years. The most frequent congenital heart disease was the transposition of great arteries. Transplanted patients with congenital heart diseases were younger, had fewer comorbidities, and a higher number of previous interventions (P < .05). There were no significant differences in extracorporeal circulation time, reoperation for bleeding, or hospital stay. The survival rates for the congenital group were 97.1%, 90.1%, 75.3%, and 52.6% at 1, 5, 10, and 20 years, respectively. Compared to the non-congenital group, congenital patients had significantly higher survival rates (HR: 0.44; 95% CI: 0.22-0.9; P = .024).
Conclusions
The number of congenital heart disease patients requiring transplantation is growing sharply. Despite their greater complexity, these patients have similar surgical outcomes and better long-term survival. Team planning and preparation will be crucial.
{"title":"Resultados a corto y largo plazo tras trasplante cardíaco en pacientes con cardiopatías congénitas","authors":"Marta Molina , Elena Roselló , Manel Tauron , Juan F. Tabilo , Constanza Fernandez , Carla Gotsens , Exzequiel Pueblas , José Montiel , Sandra Casellas , Angela Irabien , Laura Corominas , Laura López , Sonia Mirabet , Antonino Ginel","doi":"10.1016/j.circv.2024.08.001","DOIUrl":"10.1016/j.circv.2024.08.001","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Survival and the need for transplantation in patients with congenital heart disease have increased. This study aims to understand the perioperative characteristics and long-term survival of these patients after transplantation and to compare them with those of patients with non-congenital heart disease.</div></div><div><h3>Methods</h3><div>Patients who underwent a heart transplant at our center from 1984 to 2023 were included. A retrospective cohort study (congenital/non-congenital) with long-term follow-up was conducted. Statistical analysis was performed using Stata.</div></div><div><h3>Results</h3><div>A total of 636 transplanted patients were included, of which 37 had congenital heart disease. The number of transplanted patients with congenital heart disease has increased; 59.5% of such patients was transplanted in the last 10<!--> <!-->years. The most frequent congenital heart disease was the transposition of great arteries. Transplanted patients with congenital heart diseases were younger, had fewer comorbidities, and a higher number of previous interventions (<em>P</em> <!--><<!--> <!-->.05). There were no significant differences in extracorporeal circulation time, reoperation for bleeding, or hospital stay. The survival rates for the congenital group were 97.1%, 90.1%, 75.3%, and 52.6% at 1, 5, 10, and 20<!--> <!-->years, respectively. Compared to the non-congenital group, congenital patients had significantly higher survival rates (HR: 0.44; 95%<!--> <!-->CI: 0.22-0.9; <em>P</em> <!-->=<!--> <!-->.024).</div></div><div><h3>Conclusions</h3><div>The number of congenital heart disease patients requiring transplantation is growing sharply. Despite their greater complexity, these patients have similar surgical outcomes and better long-term survival. Team planning and preparation will be crucial.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 9-13"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143143575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.11.001
Claudia Escabia , Victoria Delgado
{"title":"Procalcitonina después de cirugía cardiaca: sí pero no, quizás","authors":"Claudia Escabia , Victoria Delgado","doi":"10.1016/j.circv.2024.11.001","DOIUrl":"10.1016/j.circv.2024.11.001","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 3-4"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143143574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.circv.2024.03.005
Ignacio Morales-Rey , Sara Vázquez , Brayan Rubio , Elena Sandoval , Daniel Pereda
Fulminant myocarditis may present with a variety of EKG changes. In some cases, these changes do correlate with the severity of the disease. We present the case of a young female who was admitted with ST-segment elevation in anterior leads and evolved to an aberrant QRS complex followed by asystole in less than 48 hours. Despite adequate medical therapy and mechanical circulatory support, the myocardium never recovered, and she needed an urgent heart transplant.
{"title":"Treinta y seis horas de cambios eléctricos en la miocarditis fulminante","authors":"Ignacio Morales-Rey , Sara Vázquez , Brayan Rubio , Elena Sandoval , Daniel Pereda","doi":"10.1016/j.circv.2024.03.005","DOIUrl":"10.1016/j.circv.2024.03.005","url":null,"abstract":"<div><div>Fulminant myocarditis may present with a variety of EKG changes. In some cases, these changes do correlate with the severity of the disease. We present the case of a young female who was admitted with ST-segment elevation in anterior leads and evolved to an aberrant QRS complex followed by asystole in less than 48<!--> <!-->hours. Despite adequate medical therapy and mechanical circulatory support, the myocardium never recovered, and she needed an urgent heart transplant.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 1","pages":"Pages 21-22"},"PeriodicalIF":0.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140782274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.circv.2024.03.002
The high prevalence of venous insufficiency has led to an important development in its treatments. Open surgery continues to be the technique of choice in many centers due to its excellent results and low recurrence rate. The use of mini-invasive techniques provides great benefits to the patient with less risk of associated complications and an immediate return to work. We will talk about the open surgery as well as its advantages and disadvantages in relation to other less invasive procedures.
{"title":"Cirugía clásica-abierta de las várices","authors":"","doi":"10.1016/j.circv.2024.03.002","DOIUrl":"10.1016/j.circv.2024.03.002","url":null,"abstract":"<div><div>The high prevalence of venous insufficiency has led to an important development in its treatments. Open surgery continues to be the technique of choice in many centers due to its excellent results and low recurrence rate. The use of mini-invasive techniques provides great benefits to the patient with less risk of associated complications and an immediate return to work. We will talk about the open surgery as well as its advantages and disadvantages in relation to other less invasive procedures.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"31 6","pages":"Pages 287-290"},"PeriodicalIF":0.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141408416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-01DOI: 10.1016/j.circv.2024.06.001
Ivan García Martín
Abdominal aorta aneurysms present a high incidence in elderly population and are an important cause of morbi-mortality. The new endovascular aproach (EVAR) has allowed to treat an increasing number of patients, some of them not candidates for conventional surgery. Althouhg initial mortality with EVAR, in supra or infrarenal position, has been reduced, mid-term results are similar with both techniques. Larger and better registries are needed to determine the most cost/effective technique.
{"title":"Estado actual del tratamiento de los aneurismas de la aorta abdominal","authors":"Ivan García Martín","doi":"10.1016/j.circv.2024.06.001","DOIUrl":"10.1016/j.circv.2024.06.001","url":null,"abstract":"<div><div>Abdominal aorta aneurysms present a high incidence in elderly population and are an important cause of morbi-mortality. The new endovascular aproach (EVAR) has allowed to treat an increasing number of patients, some of them not candidates for conventional surgery. Althouhg initial mortality with EVAR, in supra or infrarenal position, has been reduced, mid-term results are similar with both techniques. Larger and better registries are needed to determine the most cost/effective technique.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"31 6","pages":"Pages 247-255"},"PeriodicalIF":0.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141713157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号